AzTrials
AzTrials

Post Induction HypotensionNCT06513169

Lower Extremity Elevation to Minimize Hemodynamic Instability During Induction of General Anesthesia

A study testing Group 1: LEE in people with Post Induction Hypotension, run by The University of Texas Health Science Center, Houston at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine if lower extremity elevation (LEE) will reduce the incidence of postinduction hypotension, to compare the utilization of vasoactive medications after induction in patients with LEE and patients without LEE and to determine if LEE will increase measured cardiac output Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Post Induction Hypotension
What is being tested?
Group 1: LEE
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteUnited States
Study dates
12 Aug 2024to 27 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • American Society of Anesthesiologists (ASA)3 or lower
  • Patients requiring general anesthesia

Who cannot join

  • Allergic reaction to drugs commonly used for general anesthesia including fentanyl, midazolam, propofol, ephedrine and phenylephrine
  • Pregnant women
  • Requiring rapid sequence induction
  • Prisoners
  • Patient refusal
  • Emergency Surgery

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The University of Texas Health Science Center at Houston

    Houston, Texas, 77030

Other trials in United States

About this study

Official title: Lower Extremity Elevation to Minimize Hemodynamic Instability During Induction of General Anesthesia - a Prospective Randomized Controlled Study

The purpose of this study is to determine if lower extremity elevation (LEE) will reduce the incidence of postinduction hypotension, to compare the utilization of vasoactive medications after induction in patients with LEE and patients without LEE and to determine if LEE will increase measured cardiac output

Being tested
Group 1: LEE
Keywords
hypotension
Medical subject headings
Hypotension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group 1: LEEProcedure or surgery

    Patients will be in supine position during induction with a 12" wedge placed at the level of the Achilles tendon (LEE)

Study groups in NCT06513169
Study groupRoleWhat they receive
Group 1: LEEExperimentalNot described
Receives: Procedure: Group 1: LEE
Group 2: no LEENo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of participants that demonstrate hypotension

    Hypotension is defined as the reduction in mean arterial pressure by 20% or greater comparing the blood pressure measured before induction of anesthesia

    Measured: From start of anesthesia upto institution of positive pressure ventilation (about 5 minutes)

Secondary outcomes (5)
  1. Number of participants that demonstrate Nadir blood pressure

    Nadir blood pressure is the lowest value of blood pressure (BP) that can occur

    Measured: From start of anesthesia upto institution of positive pressure ventilation (about 5 minutes)

  2. Change in heart rate

    Measured: From start of anesthesia upto institution of positive pressure ventilation (about 5 minutes)

  3. Number of participants that need rescue vasoactive agents

    Measured: From start of anesthesia upto institution of positive pressure ventilation (about 5 minutes)

  4. Accumulated dose of rescue vasoactive agents

    Measured: End of study (within 15 minutes of baseline)

  5. Change in non-invasive cardiac output

    Measured: From start of anesthesia upto institution of positive pressure ventilation (about 5 minutes)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jul 2024
  2. Study start12 Aug 2024
  3. Primary completion27 Jun 2025
  4. Study completion27 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06513169
Sponsor's protocol ID
HSC-MS-22-0145
Status last verified
Feb 2026
First submitted
9 Jul 2024
Last updated
24 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Group 1: LEE in people with Post Induction Hypotension, run by The University of Texas Health Science Center, Houston at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of participants that demonstrate hypotension (time frame: From start of anesthesia upto institution of positive pressure ventilation (about 5 minutes)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in